Hyperprolactinemia in Women: Causes, Symptoms and Treatment

• A serum prolactin above about 25 ng/mL in a non-pregnant, non-lactating woman is considered raised, but the cut-off varies by lab and a single high result usually needs to be repeated.
• The most common everyday causes are pregnancy, breastfeeding, an underactive thyroid, and certain medicines (antipsychotics, anti-vomiting tablets, domperidone) — not a brain tumour.
• When prolactin stays high, it suppresses ovulation, which is why irregular periods, absent periods and difficulty conceiving are the symptoms women notice most.
• Diagnosis is a stepwise checklist: rule out pregnancy, check TSH, review medicines, repeat the test, and only then consider a pituitary MRI.
• First-line treatment is usually a dopamine agonist such as cabergoline; it lowers prolactin, restores periods and ovulation, and shrinks most prolactinomas — surgery is rarely needed.
• Once prolactin normalises, fertility often returns, so pregnancy planning and timely follow-up matter.

Hyperprolactinemia simply means your prolactin level is higher than it should be. Prolactin is made mainly by lactotroph cells in the pituitary gland, a pea-sized gland at the base of the brain. During pregnancy and breastfeeding, high prolactin is completely normal and expected because it prepares the breasts and sustains milk. Outside those situations, it should usually sit within the normal lab range — for most adult women, that is below about 25 ng/mL.

Because prolactin is a stress-sensitive hormone, a single high reading does not always mean disease. A woman who rushed through traffic, had a painful blood draw, slept badly or was anxious can show a temporary rise. That is why doctors interpret the number in context and often repeat it rather than diagnosing from one report.

Why does it matter beyond breast milk? When prolactin stays high, it suppresses the steady release of gonadotropin-releasing hormone from the brain. That dampens the LH and FSH signals your ovaries need, which interferes with ovulation and ovarian hormone production. The downstream effects are irregular or absent periods, a shorter luteal phase, difficulty conceiving, vaginal dryness, lower libido, and — if oestrogen stays low for a long time — weaker bones.

The most useful way to think about it is this: hyperprolactinemia is not a diagnosis to fear on its own. It is a clue that your hormone-control system needs to be traced systematically. Find the cause, manage it, and most women improve — periods return, discharge settles, and fertility often recovers. This matters in Indian clinical life because women are frequently shuttled between a gynaecologist, a fertility centre, a psychiatrist and a family doctor, and the prolactin clue gets lost in fragmented care. Keeping one clear record of period changes, pregnancies, medicines, thyroid history and past prolactin values is surprisingly powerful — it helps your doctor tell a one-off lab blip apart from a true pattern.

Hyperprolactinemia does not look the same in every woman. One may have milky discharge and no fertility worry; another may come only because IVF cycles are not progressing; a third may notice her periods changed after starting a psychiatric medicine. The common threads are below.

Milky nipple discharge (galactorrhea). A whitish discharge when you are not pregnant or breastfeeding, from one breast or both, spontaneous or only on pressing. It is not always present, and when it is, it does not always mean prolactin is sky-high. Many women in India hide this symptom out of embarrassment or fear it means cancer. In reality, milky bilateral discharge is far more often hormonal than cancerous — it is bloody or one-sided discharge with a lump that needs urgent breast review. If your discharge is concerning, read more on what nipple discharge can and cannot mean.

Changes in your period. This is often what drives women to care. Periods may become delayed, scanty, spaced out (every two to three months), or stop altogether. Because high prolactin blocks ovulation, you may still bleed occasionally without releasing an egg, so difficulty conceiving can appear even when the calendar looks roughly normal. This overlaps with PCOS, thyroid disease and other causes, which is why understanding what irregular periods can mean is a useful first step rather than guessing.

Trouble conceiving and lower sex drive. Raised prolactin can blunt desire through hormonal and emotional pathways, and vaginal dryness can add to it. In fertility clinics, prolactin is part of the basic workup because a woman can have a normal uterus and tubes yet still not ovulate reliably. Lower desire and vaginal dryness can both ease once the prolactin is treated.

Headaches and vision changes. These deserve attention because they can signal a larger pituitary tumour (macroadenoma) pressing on the nearby optic nerves. Women sometimes describe bumping into doorframes, trouble seeing to the side, or blurred vision. Headache alone is not specific, but headache plus period change plus discharge should raise suspicion.

Symptom interpretation is also shaped by privacy and culture. Some women never mention discharge in front of a male relative; others normalise months of absent periods as marriage stress or weight change. Asking direct but respectful questions about discharge, cycles, sexual function and fertility goals is how the diagnosis becomes visible.

High prolactin can be physiologic (pregnancy, breastfeeding, stress, exercise, nipple stimulation), medication-related, due to systemic illness, or due to pituitary disease. Thinking in tiers of likelihood keeps families calm and saves money.

Pituitary tumour (prolactinoma). The most common pathologic cause is a benign prolactin-secreting adenoma. A microadenoma is under 10 mm; a macroadenoma is 10 mm or larger. The word “tumour” frightens people, but prolactinomas are almost always non-cancerous and most respond very well to medicine — many shrink without surgery.

An underactive thyroid (hypothyroidism). This is a major reversible cause and must never be missed. When thyroid hormone is low, the brain releases more TRH, which can also stimulate prolactin. An untreated hypothyroid woman may show a high TSH and a high prolactin together, with fatigue, weight gain, constipation and hair fall. This link is very relevant in India, where hypothyroidism is common and often treated irregularly — levothyroxine taken with tea or iron, or skipped for weeks. Correct the thyroid and prolactin often normalises on its own. A prolactin test without a TSH is incomplete; learn how the thyroid affects fertility.

PCOS and systemic illness. PCOS does not usually cause very high prolactin, but mild elevations can coexist and muddy the picture because both cause irregular cycles and infertility — it helps to know how PCOD and PCOS actually differ. Chronic kidney disease and significant liver disease can also raise prolactin by altering hormone clearance. Chest wall problems — shingles, surgery, burns, repeated nipple stimulation — can stimulate prolactin too.

Medicines. Dopamine normally restrains prolactin, so drugs that block dopamine remove that brake. Antipsychotics are the biggest offenders; anti-vomiting tablets such as metoclopramide and domperidone are also frequent culprits, along with opioids, methyldopa and some antidepressants. This is so important in India that the next section is devoted to it.

Not every high number is true disease. Macroprolactin (a larger, less active form) can make the total look high without matching symptoms. Stress, assay quirks and lab variability also create confusion. A mildly raised result in a woman with no symptoms may simply need a careful repeat before any MRI. Other conditions can also mimic parts of the picture — women with Cushing's syndrome may have menstrual disturbance, and women with primary ovarian insufficiency present with absent periods and infertility but need an entirely different plan.

After a high prolactin report, one of the most practical steps is an honest medication review. Women move between psychiatry, gynaecology, fertility clinics, general medicine and local pharmacies, and each may prescribe something without flagging its prolactin effect.

Antipsychotics. Risperidone is widely used and frequently raises prolactin; families often notice only the behavioural improvement while a missed period gets blamed on stress. Haloperidol, though older, is still common and can markedly raise prolactin. Olanzapine is generally less prolactin-elevating but can still contribute in susceptible women. Crucially, never stop a psychiatric medicine abruptly — uncontrolled mental illness is far more dangerous than a lab abnormality. The psychiatrist and endocrinologist should coordinate on whether to lower the dose, switch the drug, or manage prolactin while keeping mental health stable. Indian psychiatric centres such as NIMHANS emphasise exactly this kind of endocrine monitoring, and mental-health support itself is part of care — see our guide to depression, anxiety and where to get help.

Domperidone. Used for gut motility and, informally, promoted as a milk booster after delivery. Because it raises prolactin, some women continue it longer than needed or use it without supervision. A new mother building milk supply may receive enthusiastic advice from relatives without any discussion of side effects or duration.

Metoclopramide (e.g. Perinorm). Sold for nausea, vomiting, reflux and motility, and often reused from an old prescription. It acts on dopamine pathways and can meaningfully raise prolactin.

Others. Opioid painkillers, methyldopa (sometimes used in pregnancy-related blood pressure) and certain antidepressants can contribute.

The practical lesson: every consultation should capture a complete medicine list — psychiatric drugs, nausea tablets, milk boosters, blood-pressure tablets, hormonal pills and anything bought over the counter. In many households a husband or mother-in-law stores the medicines, so the woman may not know the generic names. Asking for the physical strips, bills or a WhatsApp photo of the prescription is more reliable than memory. When a medicine is the likely cause, the answer is safe coordination, not blame — and it can spare a woman an unnecessary MRI and months of anxiety about a tumour she never had.

Good diagnosis follows a sequence rather than panic.

1. Do not over-read one result. Prolactin is pulsatile and stress-sensitive. If a first value is mildly or moderately raised, doctors often repeat it. Where possible, avoid significant stress, sex and nipple stimulation for about 24 hours before the draw, and come after a reasonably restful night. A repeat that stays high under calmer conditions means far more than one chaotic-day reading.

1. Rule out pregnancy. Pregnancy is the most common physiologic reason for high prolactin in reproductive-age women, so a urine or blood beta-hCG is essential, especially with irregular cycles.

1. Check the thyroid (TSH). Untreated hypothyroidism is a common reversible cause; correcting it can resolve the prolactin issue without any pituitary medicine. Renal and liver function may be added if the history suggests it.

1. Consider macroprolactin when the level is raised but symptoms are few or absent, or when the number and the clinical picture do not match. This can spare an asymptomatic woman expensive imaging and unnecessary treatment.

1. Pituitary MRI with contrast is the imaging test of choice — but only when the elevation is persistent and unexplained, the level is substantially high, or there are red-flag symptoms (galactorrhea with absent periods, repeated elevation with infertility, severe headaches, visual change). It is not the first step for every borderline result. This sequencing matters in India because an MRI is expensive relative to blood tests and often needs travel to a city centre; unnecessary scans impose cost and fear, while delayed imaging in a clearly symptomatic woman risks missing a treatable lesion.

1. Visual field testing is added if MRI shows a macroadenoma near the optic nerves or if there are visual symptoms.

For most women with symptomatic hyperprolactinemia from a prolactinoma or persistent unexplained elevation, dopamine agonists are first-line treatment. Dopamine naturally inhibits prolactin, so these medicines mimic that effect. They do more than lower a number: periods often become regular, discharge reduces, libido improves, ovulation returns, and any prolactinoma usually shrinks. This is why medicine, not surgery, is normally the first path.

Cabergoline is generally preferred — effective, longer-acting and often better tolerated. A common starting dose is 0.25 mg once or twice weekly, adjusted to prolactin levels, symptoms and tumour response; many women settle around 0.25 to 1 mg twice weekly. Because it is not a daily tablet, it is easier to stick with. In India, brands such as Caberlin or Cabolin (0.5 mg) are commonly used, often roughly Rs 150 to Rs 400 per tablet depending on brand, pharmacy and city. Early side effects can include nausea, dizziness, light-headedness on standing, constipation and fatigue, but most women tolerate it well when it is started low.

Bromocriptine remains an important alternative — older, more likely to cause nausea, and usually taken daily (often 2.5 to 7.5 mg/day in divided doses). It is still widely used in India for reasons of cost, familiarity or pregnancy planning. Brands such as Bromogen (2.5 mg) often fall broadly in the Rs 50 to Rs 200 range per strip-equivalent. Taking it at bedtime with food and titrating slowly helps with tolerance.

Fertility note. Dopamine agonists restore ovulation and fertility in a high proportion of appropriately selected women — guideline summaries often cite roughly 80 to 90 per cent regaining menses and fertility. That means pregnancy can happen sooner than a couple expects once treatment starts, so track cycles, plan timing, and tell your clinician promptly if you suspect pregnancy. Do not casually stop the medicine after two weeks just because discharge eased or one period returned — endocrine treatment needs follow-up labs and a clear duration plan.

Follow-up usually includes repeat prolactin and, with a prolactinoma, periodic imaging and visual checks as needed. If hyperprolactinemia is medication-induced, treatment may instead focus on safely changing the culprit drug rather than adding a dopamine agonist. The broader message: these medicines work well, but treatment should be individualised, monitored and integrated with your fertility, mental-health and budget realities. A woman who quietly stops because she felt dizzy for three days can be wrongly labelled “treatment-resistant” when the real issue was poor counselling at the start.

Most women with hyperprolactinemia will never need pituitary surgery, and even fewer will need radiation. It is worth stating plainly, because hearing “pituitary” and “tumour” makes many patients assume an operation is inevitable. It is not. Dopamine agonists are so effective for prolactinomas that surgery is reserved for specific situations: a macroadenoma threatening vision, a tumour that does not respond to medicine, inability to tolerate effective doses despite careful attempts, or diagnostic uncertainty about the lesion.

The standard operation is transsphenoidal surgery, where the surgeon reaches the pituitary through the nasal passages and sphenoid sinus rather than opening the skull. In experienced hands it can be highly effective for selected tumours. Indian tertiary centres with combined neurosurgery and endocrinology — AIIMS, PGI Chandigarh, Apollo, Fortis and other major referral hospitals — are where such cases are evaluated. The decision is rarely made by one doctor: it usually involves endocrinology, neurosurgery, ophthalmology (if vision is affected) and radiology review. Surgery can lower prolactin and relieve pressure, but it carries the usual risks of pituitary procedures, including cerebrospinal fluid leak, hormone deficits and incomplete remission.

Women with visual symptoms are a special category because timing matters more. A dopamine agonist is often still tried first, since prolactinomas can shrink quickly, but if vision is not improving or the lesion is resistant, surgery may be needed sooner. The same applies to rarer acute complications such as pituitary apoplexy.

Radiation is generally reserved for residual or recurrent tumour when medicine and surgery have not fully controlled the disease. Its effects can be slow and it can later cause pituitary hormone deficiencies, so it is used sparingly and is never first-line for ordinary hyperprolactinemia.

From a practical Indian standpoint, referral quality is the main issue. A woman with severe symptoms belongs in a centre with endocrinology, neuroradiology and pituitary-experienced neurosurgery, not pushed into hurried surgery at a small centre with no long-term endocrine follow-up. You are entitled to ask: How certain is the diagnosis? Has medicine been tried adequately? Is there visual field loss? How many pituitary cases does this team do? What endocrine follow-up will I get afterwards? Those are signs of informed care, not mistrust.

One of the most hopeful parts of this condition is that treating the prolactin problem often restores ovulation and makes pregnancy possible. Because high prolactin suppresses the signalling needed for regular egg release, normalising it frequently brings back predictable cycles and spontaneous conception. This matters in India, where women may spend months facing pressure or expensive testing before someone identifies prolactin as a correctable factor — what looked like “unexplained infertility” was often anovulation from untreated hyperprolactinemia. That is why prolactin belongs early in any trying-to-conceive workup, not only after repeated failed cycles.

Medication around conception. Both cabergoline and bromocriptine are used in women trying to conceive, but planning should be explicit. Many clinicians favour cabergoline for tolerability; bromocriptine has a long track record and is sometimes chosen when pregnancy is anticipated soon. Once pregnancy is confirmed, many endocrinologists stop the dopamine agonist to minimise drug exposure — unless there is a specific reason to continue, such as a macroadenoma at higher risk of growth. So a positive pregnancy test matters not only for obstetric care but for medication decisions.

Tumour size changes the plan. Women with prior microadenomas usually do very well, with a low risk of meaningful tumour growth in pregnancy. Women with macroadenomas need more careful planning before conceiving, ideally with shrinkage achieved first. During pregnancy, take headaches and visual symptoms seriously, because normal pituitary enlargement plus tumour tissue can occasionally cause pressure effects; visual field testing may be repeated and a non-contrast MRI considered if symptoms suggest growth. Routine repeat prolactin testing during pregnancy is generally not useful, because prolactin rises naturally then.

Expect nuance. Once cycles return, pregnancy may come quickly — welcome but emotionally abrupt if you had braced for a long journey. Others need extra fertility support because prolactin was only one piece. PCOS, tubal factors, male-factor infertility, age-related ovarian reserve or thyroid disease may still need attention, and some couples eventually consider assisted options. Reading this alongside PCOS fertility treatment or hypothyroidism in Indian women may reveal overlapping factors that deserve parallel management. Always tell your fertility specialist about any prolactinoma history, prior MRI findings and current dopamine agonist use from the start, so no team changes treatment without the full endocrine picture.

Because prolactin drives milk production, women understandably worry that a history of hyperprolactinemia or prolactinoma will stop them breastfeeding. In most women, it will not. A woman whose prolactinoma was treated successfully before pregnancy can usually breastfeed normally after delivery, as long as there is no separate obstetric or newborn barrier. Pregnancy and the postpartum period are naturally high-prolactin states, so the body is meant to make more prolactin now. Having had high prolactin outside pregnancy does not automatically make breastfeeding unsafe — a point worth repeating, because relatives often say overly simplistic things like “a pituitary problem means you must avoid feeding.”

At the same time, dopamine agonists suppress lactation because they lower prolactin — which is exactly why they are sometimes used to suppress milk when breastfeeding is not being pursued. The practical implication is simple: if you want to breastfeed, restarting cabergoline or bromocriptine immediately after delivery can interfere with supply. So postpartum medication should be planned in advance with endocrinology and obstetrics, especially after a macroadenoma or significant tumour burden.

Most women with microprolactinomas can breastfeed and resume treatment later if needed. The decision depends on symptoms, tumour size before pregnancy, and any sign of recurrence. Routine panic over a high postpartum prolactin is not useful, because it is physiologic then; clinicians watch for symptoms such as headache or visual change instead. If you remain well and want to feed, observation is often reasonable. If symptoms suggest tumour growth, specialist review is needed and the balance may shift toward restarting treatment even if it reduces milk.

The social context in India makes this emotionally charged. Breastfeeding carries strong expectations from hospital staff and in-laws, and bottle feeding is often judged harshly, so a woman with pituitary disease can feel squeezed between pressure to produce milk and fear that feeding will worsen her tumour. She needs evidence-based reassurance, not guilt. When feeding is not advisable or medicine must restart, frame it as a medical decision, not a failure of motherhood, and explain it clearly to partners and elders. Plan postpartum endocrine care — symptom monitoring, when to restart medicine, written “when to call the doctor” instructions — before discharge, not after the first family disagreement about milk supply. Knowing how periods return during breastfeeding also helps you read your own recovery.

For many families, the real question is what diagnosis and treatment will cost. The good news is that the basic workup is affordable; it is imaging and follow-up that add up, which is exactly why the right test sequence saves money.

Blood tests. Serum prolactin commonly costs about Rs 250 to Rs 700 depending on city, lab chain and whether it is part of a hormone package. Serum macroprolactin, when specifically requested, may be roughly Rs 500 to Rs 1,500. TSH is usually inexpensive and should be included early — it can save far greater downstream cost if hypothyroidism explains the rise.

MRI of the pituitary is the costlier step — often about Rs 6,000 to Rs 12,000 with contrast, higher at some centres, and subsidised after waiting at some government institutions. For a woman in a smaller town, the true cost also includes travel, a day off work and sometimes a companion's lost wage. This is why repeating prolactin properly and checking TSH before jumping to MRI is both medically sound and financially protective.

Medicines may continue for months or years. Cabergoline 0.5 mg (Caberlin, Cabolin) is often about Rs 150 to Rs 400 per tablet; since many women take half or one tablet once or twice weekly, the monthly cost can be manageable but still meaningful when combined with consultation fees. Bromocriptine is usually cheaper (Bromogen 2.5 mg broadly Rs 50 to Rs 200), but daily dosing and side effects reduce convenience. The choice is partly pharmacology and partly affordability and adherence.

Access is uneven. In metros, endocrinology and pituitary care are available through tertiary government institutions such as AIIMS and PGI Chandigarh, and private networks like Apollo and Fortis, which also coordinate ophthalmology, MRI review, fertility services and neurosurgery. In smaller towns, women rely first on general physicians or gynaecologists — which works well with a disciplined workup but can delay care if symptoms are dismissed as stress or treated only with the pill. A woman with persistent unexplained hyperprolactinemia, visual symptoms or fertility goals should not stay lost in repeated symptomatic treatment when an endocrinology opinion is clearly warranted. If you have employee insurance, CGHS, ESI or a state-supported scheme, ask specifically what is covered — even partial support for MRI or specialist consultation can change the path. Families often spend far more on repeated fertility consultations, supplements or unproven tonics than a targeted endocrine evaluation would cost. And because chronically low oestrogen from untreated high prolactin can weaken bones, longer-term care may also include attention to bone health and osteoporosis prevention.

Book a consultation — ideally with a gynaecologist or endocrinologist — if you have any of the symptoms below, especially in combination. A prolactin and TSH test is a reasonable, low-cost starting point.

• Endocrine Society — Clinical Practice Guideline: Diagnosis and Treatment of Hyperprolactinemia
• NHS — Prolactinoma
• MedlinePlus (US National Library of Medicine) — Prolactin blood test / High prolactin levels
• StatPearls (NCBI Bookshelf) — Hyperprolactinemia
• Indian Journal of Endocrinology and Metabolism — Hyperprolactinemia